All posts tagged: Tirzepatide

Ozempic, Mounjaro and the rise of lookism: Why young Indians are risking it all to lose weight | Eye News

Ozempic, Mounjaro and the rise of lookism: Why young Indians are risking it all to lose weight | Eye News

For years, 28-year-old Aditi has learnt to shrink herself in social spaces and mute herself from conversations, a desperate act to invisibilise herself. “Only my body was visible to others, not my mind. Nobody was concerned about my health or how my hormones swung wild and moody because of PCOS (polycystic ovary syndrome) and a competitive work life. They would instead judge me for being careless. All through my adult years, I only listened: ‘Have you gained weight this month?’ or ‘Your face is looking rounder, try a detox drink, buy a tummy twister, go on so and so diet.’ There was fashion advice to hide my belly bump. So, when my mother chose a champagne-coloured mermaid lehenga for my wedding, thinking it would make me look slim in the photos, she had not thought of the challenge of slipping into it,” she says. Instead of feeling joyful, her midriff sat heavy on her chest as Aditi walked into a beauty and wellness clinic near her West Delhi home to clear up her acne, another …

Fake Mounjaro injections manufactured in Gurugram flat; 2 arrested| India News

Fake Mounjaro injections manufactured in Gurugram flat; 2 arrested| India News

Authorities have unearthed a racket involving the manufacturing and sale of “fake” Mounjaro (tirzepatide) injections and arrested two persons here in this connection, an official said on Monday. The accused were importing raw drugs from China and manufacturing counterfeit injections of Mounjaro. (Representative Image/Pixabay) A nationwide alert has been issued to detect the counterfeit injections and an investigation is underway to unravel the entire network, including all those involved in this racket, Drug Control Officer Amandeep Chauhan said. He said a Health Department team raided a residential society in Sector 62 on Monday and arrested two people, including the key accused. The accused were importing raw drugs from China and manufacturing counterfeit injections of Mounjaro. The entire racket was being run from a flat in the society. The accused supplied these illegal injections through the B2B portal Indiamart, the officer alleged. Mounjaro is a weekly injectable medication for type 2 diabetes that significantly improves blood sugar control and aids weight loss. “We received information about a fake injection chain operating in Gurugram and acting on …

Obesity no longer a lifestyle disease: Why WHO’s new weight loss drug guidelines are a turning point | Health and Wellness News

Obesity no longer a lifestyle disease: Why WHO’s new weight loss drug guidelines are a turning point | Health and Wellness News

With weight-loss drugs like semaglutide and tirzepatide taking the world by the storm — the World Health Organisation (WHO) has, for the first time, released guidelines on using these therapies for the treatment of obesity — defined as a chronic, relapsing disease. While weight-loss has been treated as a cosmetic issue for years, the entry of these effective medicines has created a shift towards recognising obesity as a medical condition, which needs to be treated and managed to reduce risk of other chronic conditions like diabetes and heart diseases. Earlier this year, the inter-government agency had included these drugs in their list of essential medicines — a list that forms the basis for many country’s health systems ensuring access to them, government procurements, and medical reimbursements. What are good practices and recommendations in the guidelines? First, the therapies may be used for the treatment of obesity in all adults, except pregnant women, for long-term — meaning six months or more. This recommendation, however, remains conditional. This is because of limited data on the health impact …

Eli Lilly’s Weight Loss, Anti-Diabetes Drug Mounjaro To Be Launched In 2025

Eli Lilly’s Weight Loss, Anti-Diabetes Drug Mounjaro To Be Launched In 2025

Last Updated:December 17, 2024, 12:30 IST Not just Tirzepatide, the company plans to launch multiple newly developed products from its global portfolio in the Indian market, including cardiometabolic health, oncology, immunology and neuroscience Mounjaro, a weekly injectable drug by Eli Lilly for treating type 2 diabetes and obesity, competes with another high-profile drug, Ozempic. (Representational pic) Eli Lilly, a US-based pharmaceutical giant, plans to launch its drug, Tirzepatide, sold under the brand name Mounjaro, in the Indian market next year. Mounjaro, a weekly injectable drug by Eli Lilly for treating type 2 diabetes and obesity, competes with another high-profile drug, Ozempic (manufactured by Danish drugmaker, Novo Nordisk). The latter, brand name Ozempic (semaglutide), has not yet been launched in the Indian market. “We aim to launch Tirzepatide in India by 2025, after obtaining all necessary regulatory approvals,” Vineet Gupta, associate vice president and managing director of Eli Lilly (India), told News18. However, he said that the company hasn’t yet “finalised the pricing of Tirzepatide for India”. Gupta did not reveal its pricing strategy for the …